A truncated form of the regulatory subunit of the protein kinase CK2 (residues 1±178) has been crystallized in the presence of a fragment of the cyclin-dependent kinase inhibitor p21 WAF1 (residues 46±65) and the structure solved at 2.9 A Ê resolution by molecular replacement. The core of the CK2 dimer shows a high structural similarity with that identi®ed in previous structural analyses of the dimer and the holoenzyme. However, the electron density corresponding to the substrate-binding acidic loop (residues 55±64) indicates two conformations that differ from that of the holoenzyme structure , EMBO J. 20, 5320±5331]. Difference electron density near the dimerization region in each of the eight protomers in the asymmetric unit is attributed to between one and eight amino-acid residues of a complexed fragment of p21 WAF1 . This binding site corresponds to the solvent-accessible part of the conserved zinc®nger motif.
A truncated form of the regulatory subunit of the protein kinase CK2 (residues 1±178) has been crystallized in the presence of a fragment of the cyclin-dependent kinase inhibitor p21 WAF1 (residues 46±65) and the structure solved at 2.9 A Ê resolution by molecular replacement. The core of the CK2 dimer shows a high structural similarity with that identi®ed in previous structural analyses of the dimer and the holoenzyme. However, the electron density corresponding to the substrate-binding acidic loop (residues 55±64) indicates two conformations that differ from that of the holoenzyme structure , EMBO J. 20, 5320±5331]. Difference electron density near the dimerization region in each of the eight protomers in the asymmetric unit is attributed to between one and eight amino-acid residues of a complexed fragment of p21 WAF1 . This binding site corresponds to the solvent-accessible part of the conserved zinc®nger motif.
Introduction
Protein kinase CK2 is a ubiquitous serine/threonine kinase in eukaryotes that is known to phosphorylate more than 300 cellular proteins Meggio & Pinna, 2003) . These range from transcription factors to proteins participating in cell signalling to those involved in chromatin structure. Numerous ®ndings suggest a role for CK2 in the control of cell division, differentiation and virus infection (Pinna & Meggio, 1997; Guerra & Issinger, 1999) . Native CK2 forms heterotetrameric complexes consisting of two catalytic ( or H ) and two regulatory () subunits. The detailed structural mechanism of the regulation by the subunit of the phosphorylating activity of the catalytic subunit is not well understood, although the structures of the two separate subunits and the holoenzyme have recently been solved (Nie®nd et al., 1998 Chantalat et al., 1999) . It is clear, however, that the function of the regulatory subunit is not merely one of activating the catalysis in the -subunit, since with several substrates the regulatory subunit has been shown to be inhibitory rather than stimulatory.
An interesting feature is the presence of a highly conserved zinc-®nger domain mediating the dimerization of the CK2 subunits. The dimer has a crescent shape with a region of acidic amino acids at each extremity resulting from an acidic loop (Asp55±Asp64), which forms part of an an extended acidic groove and plays an important role in the modulation of CK2 activity (Boldyreff et al., 1993 (Boldyreff et al., , 1994b . It has also been postulated that this acidic stretch encompassing residues 55± 64 of CK2 interacts with a basic cluster of amino acids on the catalytic subunit of CK2 (i.e. residues 74±80 of CK2) within the same tetrameric CK2 complex. However, the structure of tetrameric CK2 shows that this acidic stretch is far away from the active site of the catalytic subunit.
The regulatory subunit has been found to bind several proteins that are substrates of CK2, a large proportion of which are important regulators of cell division, such as p53 (Appel et al., 1995) and p21 WAF1 (Appel et al., 1995; Go È tz et al., 1996 Romero-Oliva & Allende, 2001) . Recently, we have also shown that CK2 binds to the cyclin-dependent kinase (CDK) complex inhibitor p27 KIP1 (Tapia et al., 2004) . Such binding via the subunit is consistent with a contribution of the kinase regulatory subunits to the af®nity and selectivity of the enzyme for various substrates by providing docking sites (Holland & Cooper, 1999) , thus increasing the effective substrate concentration in the vicinity of the catalytic active site.
In order to gain further insight into the structural features of the CK2 docking site, we crystallized CK2 in the presence of a fragment of p21 WAF1 . p21
WAF1
, a universal inhibitor of cyclin-dependent kinases, regulates cell division by forming distinct protein complexes with cyclins, CDKs and the proliferating cell nuclear antigen. Previous studies have demonstrated that a region of p21 WAF1 essential for kinase inhibition, encompassing residues 46±65, binds to CK2 (Go È tz et al., 1998) .
The p21 WAF1 -binding region on the CK2 subunit has been a source of controversy. Far-Western assays implicate three regions: an N-terminal region (residues 9±31), an intermediate region (residues 49±63), which encompasses the acidic loop, and the C-terminal (201±215) region of CK2 . However, recent pull-down experiments do not support binding to the acidic loop or the C-terminus of CK2, but underline the importance of the N-terminal region 1±44 (Romero-Oliva & Allende, 2001 ). Both studies were carried out using full-length p21 WAF1 . Moreover, the medium region 71±150 of CK2 was not reported to bind wild-type p21 WAF1 . It has also been suggested that the solventaccessible region in the zinc-®nger motif may be important for binding substrates (Chantalat et al., 1999) .
In this work, we use a C-terminal truncated form of the CK2 subunit, residues 1±178, for crystallization in the presence of a fragment of p21 WAF1 , residues 46±65. We report two new conformations of the substrate-binding acidic loop that differ from that in the holoenzyme structure. Our study suggests that the binding site of p21 WAF1 to CK2 1±178 corresponds to the solvent-accessible part of the conserved zinc®nger motif. p21 WAF1 is likely to adopt a non-globular conformation to bind CK2.
Materials and methods

Protein purification
The gene encoding CK2
1±178 from Xenopus laevis (100% sequence identical to the human) was fused to the glutathione S-transferase gene by cloning into the vector pGEX-2T (Amersham) at the EcoRI restriction site for both 5 H and 3 The completeness of digestion of the fusion protein was monitored by SDS±PAGE. The cleavage leaves six additional residues at the N-terminal extremity of CK2, as con®rmed by N-terminal sequencing. After cleavage, the protein solution was pumped through the glutathione Sepharose 4B column to remove the GST fragment. The CK2 1±178 protein was loaded onto a Resource Q ionexchange column (Amersham) and eluted using a linear gradient from 0.2 to 1 M NaCl. Samples were further puri®ed by gel ®ltration (Superdex 200 HR 10/30 column; equilibrated and eluted with buffer A). Gel-®ltration experiments con®rmed that the protein forms a dimer in solution. The puri®ed protein was concentrated to 15±20 mg ml À1 using a Centricon (10 kDa cutoff).
A peptide containing residues 46±65 of p21 WAF1 was synthesized using a Pioneer peptide synthesiser (Applied Biosystems). The peptide identities were corroborated by laser-desorption mass spectrometry and HPLC analysis.
A twofold molar excess of p21 WAF1 was added to a concentrated sample of puri®ed CK2
1±178 , usually at 20 mg ml
À1
. The mixture was left to equilibrate overnight at 277 K before setting up any crystallization screens. The hanging-drop vapour-diffusion method was used to screen crystallization conditions. The ®rst crystals were obtained in a solution containing 20% PEG 4000 and 20% 2-propanol from a sparse-matrix kit (Hampton Research). Plate-like crystals formed after 2 d equilibration at room temperature against a well solution of 20% polyethylene glycol 4000 (PEG 4000) in Bicine buffer pH 9.2, 30 mM MgCl 2 , 1 mM DTT and 5% 2-propanol. Drops using the same conditions, without addition of the p21 WAF1 peptide, were set up for comparison.
Crystal characterization
Several large crystals were harvested from their crystallization drops and washed in a 10±20 ml drop of stabilizing solution. The stabilizing solution typically contained 5% more precipitant agent than the reservoir solution of the corresponding crystallization condition. After 2±4 min, the crystals were transferred again into a fresh drop of stabilizing solution. The procedure was repeated four to ®ve times to ensure that no layer of the original protein solution was still present on the research papers surface of the crystal. The crystals were then dissolved in water for MALDI±TOF analysis and in 5 ml loading buffer for SDS± PAGE analysis.
X-ray data collection
The crystals were soaked for several minutes in a cryoprotecting solution containing 20% PEG 4000, 5% 2-propanol, 400 mM NaCl, 30 mM MgCl 2 , 50 mM Bicine pH 9.2 and 20% glycerol. The diffraction data were collected from a single crystal at 100 K to 2.9 A Ê resolution at synchrotron beamline ID14-1 (ESRF, Grenoble). The X-ray data were processed using the program MOSFLM (Leslie, 1992) and scaled and reduced using programs from the CCP4 suite (Collaborative Computational Project, Number 4, 1994) .
Small-angle X-ray scattering (SAXS) data were collected at station 2.1 at the SRS (Daresbury, UK). CK2
1±178 solutions in 50 mM Tris±HCl buffer pH 8.0 were analysed at 293 K. Distance-distribution functions &(r) and the radius of gyration R g were evaluated with the indirect Fourier transform using the program GNOM (Svergun, 1991) .
Structure determination, model building and refinement
The crystal structure was determined by molecular replacement using that of CK2 as a search probe (PDB code 1qf8; Chantalat et al., 1999) , with MOLREP performing rotation and translation searches. An initial correlation coef®cient of 58.3% was obtained. The re®nement was performed using REFMAC5, ®rst through restrained re®nement and subsequently by de®ning TLS groups corresponding to each protomer. Further steps of re®nement were performed with CNS energy minimization and B-factor re®nement using bulksolvent correction. Tight NCS restraints for atomic coordinates and B factors were applied to main-chain and side-chain atoms. Atoms from the N-and C-termini, as well as the acidic loop, were excluded from these restraints. Torsion simulated annealing was performed and an (F o À F c ) difference map generated to assess the presence of the peptide using CNS sa_omit_map (starting temperature, 4000 K; drop, 25 K per set; Bru È nger et al., 1998).
Results
Overall structure analysis
Analysis of the plate-like crystals by SDS±PAGE con®rmed the presence of CK2
1±178
. The space group, P2 1 2 1 2, of the crystals of CK2
1±178 differs from that of the previous structure of the CK2 subunit (P4 1 2 1 2; Chantalat et al., 1999) . The structure was solved at a resolution of 2.9 A Ê and re®ned to a crystallographic R factor of 23.8% and R free of 26.6% (see Table 1 ). The quality of the map allowed rebuilding of the main part of the core regions (Fig. 1) . The overall tertiary structure of CK2 1±178 shows the expected crescent-shaped CK2 dimer (Fig. 2) .
The CK2 protomer consists of two tightly packed domains. Domain I is predominantly helical in nature and forms a characteristic L-shape as observed in the previous CK2 dimer structure. Domain II consists of a three-stranded antiparallel -sheet with four conserved cysteines (109, 114, 137 and 140) Stereoview of the re®ned model and 2F o À F c electron-density map in a part of the core region of CK2. The electron-density map is contoured at 1.0' above the mean density. Figs. 1, 2 , 4, 5 and 7 were drawn using PyMOL (DeLano, 2002).
Figure 2
Ribbon representation of the CK2 1±178 dimer structure. The blue and purple residues correspond to the polyalanine model. The Zn atoms are represented by blue spheres.
Figure 3
Root-mean-square variation in distance among the eight NCS-related protomers in the CK2 1±178 structure (a), between the chain A and chains from 1qf8 (b) and between the chain A and chains from 1jwh (c). Calculations were made using LSQMAN (Kleywegt, 1996) . Graphs are shifted from the origin for clarity.
forming a Zn 2+ -binding motif. However, the characteristic -helix of classical zinc ®ngers is not present in this motif. The CK2 zinc motif is remarkably similar to the Zn 2+ -ribbon of transcriptional elongation factor TFIIS, as reported earlier (Qian et al., 1993; Chantalat et al., 1999) .
The above-mentioned acidic loop is located at the remote extremities of the dimer. Some residues in the termini and acidic loop regions could not be ®tted into the electron density of some of the protomers and may be disordered, as observed in earlier structures of CK2 (see list of residues in Table 2 ). As shown in Table 2 , our overall structure is very similar to that of the CK2 dimer (Chantalat et al., 1999) and of the holoenzyme (PDB code 1jwh; , indicating the absence of major reorganization of the subunit in the presence of p21 WAF1, 46±65 . SAXS experiments were performed on CK2
1±178 at concentrations ranging from 1 to 10 mg ml À1 ($50±500 mM).
CK2
1±178 showed an estimated gyration radius (R g ) of 27.5 A Ê . This result demonstrates that within this concentration range CK2
1±178 forms monodisperse dimers and no higher aggregates in aqueous solution. The overall shape of the electron density observed in solution is in good agreement with that determined from the Xray structures.
Acidic loop
The most signi®cant differences between the CK2 1±178 structure and that of the holoenzyme (PDB code 1jwh; arise in the acidic loop, residues 55±64 (Fig. 3) . This region was suggested as a potential binding site for p21 WAF1 and other substrates (Meggio et al., 1994; Chen et al., 1996; Leroy, Heriche et al., 1997; Romero-Oliva & Allende, 2001 ). This acidic loop was not visible in the electron-density maps of the earlier CK2 dimer structure (Chantalat et al., 1999) , suggesting that this region adopts more than one conformation.
The present crystal structure of CK2 1±178 shows the main-chain back- Stereoview of a peptide polyalanine model in the omit F o À F c electron-density map. Residues from the peptide are printed in blue and contact the dimerization interface of the CK2 1±178 dimer formed by the J (orange) and K (green) protomers. The difference electron-density map is contoured at 3.0' above the mean density.
Figure 6
Alignment of p21 WAF1 sequences from Homo sapiens, Felis silvestris catus, Mus musculus, Rattus norvegicus and Gallus gallus. The region corresponding to residues 46±65 of p21 WAF1 is indicated in blue. The alignment was produced using CLUSTALW (Thompson et al., 1997) .
bone of the acidic loop to be clearly de®ned in three of the eight protomers in the asymmetric unit (Fig. 4b) . Moreover, two different conformations (1 and 2) are observed within these three protomers, diverging from Pro58 to Gln68 (Fig.  4a) .
In two of the protomers (chain E and J), the acidic loop folds into a compact conformation (conformation 1; Fig. 4a ), which differs from that reported in the holoenzyme structure. In conformation 1, the 4 -helix is followed by a turn in residues Asp59±Asp64, as de®ned by DSSP (Kabsch & Sander, 1983) . In the third protomer (chain A), the loop adopts conformation 2, diverging from residues 61±67. The loop is presumed to be disordered in the other protomers.
The rest of the molecule shows great similarity: the maximum r.m.s.d. between the main-chain atoms of two NCSrelated protomers excluding the loop is 0.29 A Ê .
Ligand binding
The presence of p21 WAF1 in the crystal structure was con®rmed from the MALDI±TOF spectrum of dissolved crystals and the fact that no crystal could be grown in the absence of p21 WAF1 using identical crystallization conditions. No remaining signi®cant positive peaks could be seen in the difference map around those regions where the acidic loop could be traced. It is therefore improbable that the fragment 46±65 of p21 WAF1 binds to this region of CK2.
Continuous electron density could be seen near to the dimerization region of CK2. The electron density still appears at the 3.0' contour level in the omit map generated after simulated annealing using CNS (Fig. 5) . This density allowed us to ®t a polyalanine backbone of one to eight residues within the eight protomers of the asymmetric unit. It is improbable that this electron density corresponds to a disordered portion of the N-or C-terminus, as the distances are large.
On the CK2 side, the contact region includes residues Tyr113 and Glu115 from one protomer and Leu124, Glu130, Ala131, Lys134, Thr145 and His152 from the other. This region corresponds to the solvent-accessible part of the highly conserved zinc-®nger motif and is therefore consistent with the observation of Chantalat et al. (1999) that some of the exposed and conserved segments (including Gly123±Ile127) of the zinc-®nger motif were accessible for interactions with other molecules.
On the p21 WAF1 side, the CK2 1±178 structure is consistent with the identi®cation by Go È tz et al. (1998) of a binding site for p21 WAF1 somewhere in the 46±65 region of the peptide. Moreover, alignment of the available sequences of p21
WAF1
shows that this stretch of amino acids is highly conserved, particularly in the 48±61 region (Fig. 6) .
Conclusions
This new crystal form con®rms the great¯exibility of the acidic activation loop of the regulatory subunit CK2. However, the acidic loop still lies far away from the active site of CK2 catalytic subunit, as observed by . The superimposition of CK2 according to the holoenzyme structure indicates a distance exceeding 30 A Ê in the most favourable conformation. This separation contrasts with the observation that the acidic loop in¯uences the intramolecular autophosphorylation of Ser2 of CK2 (Boldyreff et al., 1994a) , unless (i) the great¯exibility of the activation loop enables it to adopt a conformation in which it binds the N-terminal region ) and/or (ii) this`auto'-phosphorylation mechanism results from the formation of higher order CK2 holoenzyme structures (Glover, 1986; Valero et al., 1995; Rekha & Srinivasan, 2003; Litch®eld, 2003 crystal packing of the CK2 holoenzyme in the 1jwh structure gives clues about the nature of such a higher order assembly; the active site of a symmetrically related CK2 molecule is intercalated between the N-terminal and the activation loop of CK2. The putative binding region for p21 WAF1 is similar to that implicated in related CDK inhibitors of CK2 regulatory subunit, as region 72±149 of CK2 has been suggested to interact with p53 (Appel et al., 1995) . This comparison is particularly striking as p53 was shown to compete with p21 binding and probably shares a common binding site (Go È tz et al., 1996) . Recent results suggest that p21
WAF1 competition with other substrates may indeed be the main inhibitory mechanism of CK2 activity (Romero-Oliva & Allende, 2001) .
Moreover, this binding site supports the hypothesis that p21 WAF1 may adopt an extended non-globular conformation when binding to the CK2 holoenzyme for the following reasons.
(i) The cyclin-dependent kinase inhibitor p27 KIP1 , which shows a high sequence similarity to p21 WAF1 (sequence identity = 39.7% and E value = 3.1 Â 10 À7 according to FASTA3; Pearson & Lipman, 1988 ) is mainly unfolded in aqueous solution and adopts a non-globular conformation in a ternary complex with CDK2/cyclin A (Russo et al., 1996; Flaugh & Lumb, 2001) . Ongoing SAXS experiments show that in binding CK2, p27
KIP1 might retain a primarily non-globular conformation (unpublished results). The sequence similarity between p21 WAF1 and p27 KIP1 , as well as secondary-structure prediction using PHD (Rost & Sander, 1993) , suggest that the p21 WAF1 structure is similar to that of p27 KIP1 . Indeed, limited proteolysis, CD and NMR analyses have previously shown p21 WAF1 to be unstructured in solution, as is p27 KIP1 (Kriwacki et al., 1996) .
(ii) The different interacting regions mentioned in p21 WAF1 -binding assays to CK2 (Go È tz et al., 1998 Romero-Oliva & Allende, 2001 ) lie in a continuous band at the surface of the CK2 structure (Fig. 7) .
(iii) It has been previously reported that p21 WAF1 probably binds both catalytic and regulatory subunits of CK2 (Go È tz et al., 1998) .
(iv) The crystal structure of CK2 showed that an extended linear ridge of conserved residues is wrapped around the dimer structure (Chantalat et al., 1999) . The conserved polybasic C-terminal region of p21
WAF1
, not included in our peptide, most probably interacts with the acidic loop of CK2 , which is at the distal extremity of the previously mentioned interacting band. The interaction of this region of CK2 with wild-type p21 WAF1 was demonstrated by FarWestern blot and pull-down assays (Romero-Oliva & Allende, 2001; . Additional potential binding sites may include the far C-terminal region of CK2 (201±215) (Romero-Oliva & Allende, 2001; .
The study of interactions of p21 WAF1 with CK2 using small peptide fragments may not be an effective way of identifying all binding sites of the full-length p21 WAF1 . It is clear that weak interactions in individual regions may act cooperatively to give tight binding to the CK2 holoenzyme. This could partly explain the discrepancies among several binding studies of p21 WAF1 to CK2 (Go È tz et al., 1998 Romero-Oliva & Allende, 2001 ).
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